Denise Pollard-Knight, Director at OncoMed Pharmaceuticals Inc (OMED), bought 2,122,807 shares at $17.00 ($1.0M) on 2013-07-23, disclosed to the SEC on 2013-07-23.
Open-market purchase of $1.0M OMED by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,063,983 | $0 | 0.0% |
| 2 | $17.00 | 58,824 | $1.0M | 100.0% |
| Total | $0.47 avg | 2,122,807 | $1.0M | 100% |
| Filing → |
| OMED | SELL | 2014-12-23 | $448K | — | Filing → |
| OMED | SELL | 2014-12-10 | $717K | — | Filing → |
| OMED | SELL | 2014-12-05 | $540K | — | Filing → |